03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Oruvail 200* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Aventis Pharma, Dagenham |
Origin | UK |
Manufacturer | Aventis Pharma UK |
Origin | UK |
ATC | M01AE03 |
Oruvail 200* :
Oruvail 200* :
Oruvail 200* :
Oruvail 200* :
Oruvail 200* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Agranulocytosis | Not known |
Alopecia | Not known |
Anaemia | Rare |
Anaphylactic reactions | Not known |
Anaphylactic shock | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Asthmatic attack | Rare |
Blood bilirubin increased | Rare |
Bone marrow depression | Not known |
Bronchospasm | Not known |
Bullous disorder | Not known |
Cardiac failure | Not known |
Cephalea | Uncommon |
Colitis | Rare |
Colitis aggravated | Not known |
Constipation | Uncommon |
Convulsion | Not known |
Crohns disease aggravated | Not known |
Diarrhoea (Diarrhea) | Uncommon |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Not known |
Dyspepsia | Common |
Eruption | Uncommon |
Fatigue | Uncommon |
Flatulence | Uncommon |
Fluid retention | Not known |
Gastritis | Uncommon |
Gastroduodenal haemorrhage | Not known |
Gastrointestinal perforation | Not known |
Hepatitis | Rare |
Hyperkalaemia | Not known |
Hypertension | Not known |
Interstitial nephritis | Not known |
Kidney function abnormal | Not known |
Leucopenia (Leukopenia) | Rare |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Mood disorders | Not known |
Nausea | Common |
Nephrotic syndrome | Not known |
Oedema | Uncommon |
Paraesthesia (paresthesia) | Rare |
Peptic ulcer | Rare |
Photosensitivity | Not known |
Pruritus | Uncommon |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Not known |
Renal papillary necrosis | Not known |
Renal tubular necrosis | Not known |
Rhinitis | Not known |
Skin rash | Uncommon |
Sodium retention | Not known |
Somnolence | Uncommon |
Stevens-Johnson syndrome | Not known |
Stomach ache | Common |
Stomatitis | Rare |
Thrombocytopenia (Thrombopenia) | Not known |
Tinnitus | Rare |
Transaminases increased | Rare |
Urticaria | Not known |
Urticaria aggravated | Not known |
Vasodilation | Not known |
Vertigo | Uncommon |
Vision blurred | Rare |
Vomiting | Common |
Weight increased (weight gain) | Rare |
Oruvail 200* :
NB : Products With Same Indication |
Different Units By MoH Code
Oruvail 200* MoH 1776 :
Form | Capsule, hard |
Package Size | Box of 28 |
Strength | 200mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 26442 |
Submission date | 01/01/1988 |
Registration Year | 1988 |
Archived Date | 2014 |
Price Comparison
● Country: | Qatar | |
● Package Size: | 28 | |
● Public Price: | 49.25 QAR | ( 1,209,481.50 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,7589 QAR | ( 24,558.00 LBP ) |
● Pharmacy Price: | 40.26 QAR | ( 988705.08 LBP ) |
● Pricing Date: | 20/07/2017 | |
● Type: | Medicine Non Marketed |
● Country: | Abu Dhabi | |
● Package Size: | 28 | |
● Public Price: | 48 AED | ( 1,159,728.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,7143 AED | ( 24,161.00 LBP ) |
● Pharmacy Price: | 39 AED | ( 942279 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 28's (14's Blister x 2) | |
● Public Price: | 48 AED | ( 1,159,728.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,7143 AED | ( 24,161.00 LBP ) |
● Pharmacy Price: | 39 AED | ( 942279 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 28 | |
● Public Price: | 5.16 OMR | ( 1,190,587.44 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,1843 OMR | ( 0.00 LBP ) |
● Pricing Date: | 15/12/2018 | |
● Type: | Medicine Non Marketed |
● Country: | UK | |
● Package Size: | 28 | |
● Public Price: | 23.85 GBP | ( 2,710,528.65 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,8518 GBP | ( 0.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 28 | |
● Public Price: | 9.13 EUR | ( 884,477.88 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,3261 EUR | ( 0.00 LBP ) |
● Exfactory Price: | 10 EUR | |
● Pricing Date: | 09/10/2020 | |
● Type: | Medicine Authorised |
● Country: | New Zealand |
● Package Size: | 28 cap |
● Exfactory Price: | 12.07 NZD |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 01/04/2020 |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File